Search Results

There are 1331 results for: content related to: The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett’s oesophagus

  1. Pharmacokinetics and Relative Bioavailability of a Fixed-Dose Combination of Enteric-Coated Naproxen and Non-Enteric-Coated Esomeprazole Magnesium

    The Journal of Clinical Pharmacology

    Volume 52, Issue 5, May 2012, Pages: 670–680, Dr Laurene Wang-Smith, Dr John Fort, Mr Ying Zhang and Dr Mark Sostek

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011405500

  2. You have free access to this content
    The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety

    Alimentary Pharmacology & Therapeutics

    Volume 15, Issue 7, July 2001, Pages: 927–935, N. B. Vakil, R. Shaker, D. A. Johnson, T. Kovacs, R. D. Baerg, C. Hwang, D. D'Amico and B. Hamelin

    Version of Record online : 12 JAN 2002, DOI: 10.1046/j.1365-2036.2001.01024.x

  3. You have free access to this content
    Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 2, July 2008, Pages: 187–199, R. H. HUNT, D. ARMSTRONG, M. YAGHOOBI, C. JAMES, Y. CHEN, J. LEONARD, J. M. SHIN, E. LEE, D. TANG-LIU and G. SACHS

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2036.2008.03725.x

  4. You have free access to this content
    Combined analysis of three crossover clinical pharmacology studies of effects of rabeprazole and esomeprazole on 24-h intragastric pH in healthy volunteers

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 4, February 2007, Pages: 501–510, V. NORRIS, K. BAISLEY, K. DUNN, S. WARRINGTON and A. MOROCUTTI

    Version of Record online : 22 JAN 2007, DOI: 10.1111/j.1365-2036.2006.03221.x

  5. You have free access to this content
    Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 7, July 2000, Pages: 861–867, Lind, Rydberg, Kylebäck, Jonsson, Andersson, Hasselgren, Holmberg and Röhss

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00813.x

  6. You have free access to this content
    Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 10, May 2016, Pages: 1048–1059, T. Kagami, S. Sahara, H. Ichikawa, T. Uotani, M. Yamade, M. Sugimoto, Y. Hamaya, M. Iwaizumi, S. Osawa, K. Sugimoto, H. Miyajima and T. Furuta

    Version of Record online : 18 MAR 2016, DOI: 10.1111/apt.13588

  7. Long-term management of patients with symptoms of gastro-oesophageal reflux disease – a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting

    International Journal of Clinical Practice

    Volume 60, Issue 1, January 2006, Pages: 15–22, Å. N. Hansen, 1 R. Bergheim, 2 H. Fagertun, 3 H. Lund, 4 I. Wiklund and 5 B. Moum 6

    Version of Record online : 20 DEC 2005, DOI: 10.1111/j.1368-5031.2006.00768.x

  8. Pharmacokinetic and Pharmacodynamic Modeling Analysis of Intravenous Esomeprazole in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 56, Issue 7, July 2016, Pages: 816–826, Dongyang Liu, Hong Yang, Ji Jiang, Péter Nagy, Kai Shen, Jiaming Qian and Pei Hu

    Version of Record online : 12 MAY 2016, DOI: 10.1002/jcph.733

  9. You have free access to this content
    Poster Presentations

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S3, October 2013, Pages: 23–693,

    Version of Record online : 17 SEP 2013, DOI: 10.1111/jgh.12363_2

  10. A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease

    International Journal of Clinical Practice

    Volume 59, Issue 6, June 2005, Pages: 665–671, A. Norman Hansen, 1 R. Bergheim, 2 H. Fagertun, 3 H. Lund and 4 B. Moum 5

    Version of Record online : 25 MAY 2005, DOI: 10.1111/j.1368-5031.2005.00564.x

  11. You have free access to this content
    Esomeprazole — enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 4, February 2003, Pages: 481–488, P. Lindberg, D. Keeling, J. Fryklund, T. Andersson, P. Lundborg and E. Carlsson

    Version of Record online : 5 MAR 2003, DOI: 10.1046/j.1365-2036.2003.01481.x

  12. You have free access to this content
    Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study

    Alimentary Pharmacology & Therapeutics

    Volume 20, Issue 4, August 2004, Pages: 399–406, P. O. Katz, D. O. Castell, Y. Chen, T. Andersson and M. B. Sostek

    Version of Record online : 21 JUL 2004, DOI: 10.1111/j.1365-2036.2004.02079.x

  13. You have full text access to this Open Access content
    The Influence of Esomeprazole and Cisapride on Gastroesophageal Reflux During Anesthesia in Dogs

    Journal of Veterinary Internal Medicine

    Volume 26, Issue 3, May-June 2012, Pages: 518–525, A.C. Zacuto, S.L. Marks, J. Osborn, K.L. Douthitt, K.L. Hollingshead, K. Hayashi, A.S. Kapatkin, B.H. Pypendop and P.C. Belafsky

    Version of Record online : 10 APR 2012, DOI: 10.1111/j.1939-1676.2012.00929.x

  14. You have free access to this content
    A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 1, January 2010, Pages: 150–159, N. G. HUNFELD, D. J. TOUW, R. A. MATHOT, P. G. H. MULDER, R. H. VAN SCHAIK, E. J. KUIPERS, J. C. KOOIMAN and W. P. GEUS

    Version of Record online : 24 SEP 2009, DOI: 10.1111/j.1365-2036.2009.04150.x

  15. Effect of esomeprazole, a proton pump inhibitor on the pharmacokinetics of sonidegib in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 82, Issue 4, October 2016, Pages: 1022–1029, Jocelyn Zhou, Michelle Quinlan, Kelli Glenn, Hildegard Boss, Franck Picard, Henry Castro and Dalila Sellami

    Version of Record online : 13 JUL 2016, DOI: 10.1111/bcp.13038

  16. You have free access to this content
    Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 4, August 2015, Pages: 368–375, M. Teng, A. L. Khoo, Y. J. Zhao, L. Lin, B. P. Lim, T. S. Wu and Y. Y. Dan

    Version of Record online : 20 APR 2015, DOI: 10.1111/jcpt.12277

  17. You have free access to this content
    A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 7, April 2012, Pages: 810–818, N. G. Hunfeld, D. J. Touw, R. A. Mathot, R. H. van Schaik and E. J. Kuipers

    Version of Record online : 13 FEB 2012, DOI: 10.1111/j.1365-2036.2012.05014.x

  18. You have free access to this content
    Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care – prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg

    Alimentary Pharmacology & Therapeutics

    Volume 29, Issue 9, May 2009, Pages: 967–978, A. EGGLESTON, P. H. KATELARIS, S. NANDURKAR, P. THORPE, G. HOLTMANN and ON BEHALF OF THE TREAT STUDY GROUP

    Version of Record online : 3 FEB 2009, DOI: 10.1111/j.1365-2036.2009.03948.x

  19. You have free access to this content
    The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover study

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 5, September 2014, Pages: 548–561, J. S. Shin, J. Y. Lee, K. H. Cho, H. L. Park, M. Kukulka, J.-T. Wu, D. Y. Kim and S.-H. Park

    Version of Record online : 13 JUL 2014, DOI: 10.1111/apt.12860

  20. You have free access to this content
    Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 3, February 2003, Pages: 333–341, K. Lauritsen, J. Devière, M.-A. Bigard, E. Bayerdörffer, G. Mózsik, F. Murray, S. Kristjánsdóttir, V. Savarino, K. Vetvik, D. De Freitas, V. Orive, L. Rodrigo, M. Fried, J. Morris, H. Schneider, S. Eklund and A. Larkö

    Version of Record online : 11 MAR 2003, DOI: 10.1046/j.1365-2036.2003.01464.x